Effect of phosphorylated cyclocytidine on deoxyribonucleic acid polymerase.
D000812:Anhydrides / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D000970:Antineoplastic Agents / Q000378:metabolism / Q000494:pharmacology*; D002250:Carbon Radioisotopes; D003561:Cytarabine / Q000494:pharmacology; D003597:Cytosine Nucleotides / Q000378:metabolism / Q000494:pharmacology*; D004254:DNA Nucleotidyltransferases / Q000037:antagonists & inhibitors*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D007939:Leukemia L1210 / Q000201:enzymology / Q000378:metabolism; D007942:Leukemia, Experimental / Q000201:enzymology / Q000378:metabolism; D008297:Male; D051379:Mice; D009705:Nucleosides; D010770:Phosphotransferases / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000812:Anhydrides; D000970:Antineoplastic Agents; D002250:Carbon Radioisotopes; D003597:Cytosine Nucleotides; D004273:DNA, Neoplasm; D009705:Nucleosides; D003561:Cytarabine; D014316:Tritium; D010770:Phosphotransferases; D004254:DNA Nucleotidyltransferases; D013936:Thymidine